Does erythropoietin therapy affect circulating endothelial cells in hemodialysis patients?

Anemia is a common complication of chronic kidney disease (CKD). The most common cause of anemia in CKD is erythropoietin deficiency; and the most important cause of mortality in CKD patients is atherosclerotic vascular complications which are associated with endothelial damage. One of the methods...

Descripció completa

Dades bibliogràfiques

Autors principals:	T. Bulduk, A. U. Yalcin, O. M. Akay, S. G. Ozkurt, H. U. Teke, G. Sahin, G. Temiz, G. Demirel
Format:	Artigo
Idioma:	Inglês
Publicat:	National Kidney Foundation of Ukraine 2020-10-01
Col·lecció:	Український Журнал Нефрології та Діалізу
Matèries:	renal insufficiency, hemodialysis, erythropoietin, circulating endothelial cell.
Accés en línia:	https://ukrjnd.com.ua/index.php/journal/article/view/446
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!